HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postexposure prophylaxis for rabies in resource-limited/poor countries.

Abstract
Human rabies is essentially a fatal disease once clinical signs develop. Rabies postexposure prophylaxis (PEP) consists of thorough wound care in combination with administration of rabies immunoglobulin and rabies vaccine. This is highly effective in rabies prevention if carried out diligently. Preexposure rabies prophylaxis simplifies PEP in the event of an exposure by eliminating the need for immunoglobulin. Shortened and more convenient and economical PEP regimens are being developed with promising results. They reduce the cost of PEP as well as travel expenses for the often very poor patients. The intradermal PEP regimen can now reduce the vaccine cost by ~60-70%. Although PEP in humans can prevent death, controlling the canine vector by sustained vaccination remains the mainstay of rabies elimination.
AuthorsPrapimporn Shantavasinkul, Henry Wilde
JournalAdvances in virus research (Adv Virus Res) Vol. 79 Pg. 291-307 ( 2011) ISSN: 1557-8399 [Electronic] United States
PMID21601051 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Immunoglobulins
  • Rabies Vaccines
Topics
  • Developing Countries
  • Humans
  • Immunoglobulins (administration & dosage)
  • Post-Exposure Prophylaxis (economics, methods)
  • Rabies (prevention & control)
  • Rabies Vaccines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: